CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
Background The CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) is a key regulator of the programed death receptor ligand-1 (PD-L1) protein. However, the usefulness of CMTM6 expression as a prognostic indicator and the relationship between CMTM6 and PD-L1 expression in gastric cancer (GC)...
Main Authors: | Xin Li, Ling Chen, Chuan Gu, Qiaoli Sun, Jia Li |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-08-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/9536.pdf |
Similar Items
-
Co-Expression with Membrane CMTM6/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1/L1 Therapeutic Efficacy in Gastric Adenocarcinoma
by: Ziqi Wang, et al.
Published: (2021-10-01) -
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
by: Tong Zhang, et al.
Published: (2022-07-01) -
Expression and clinical significance of CMTM1 in hepatocellular carcinoma
by: Song Xin, et al.
Published: (2021-01-01) -
CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
by: Daqi Jia, et al.
Published: (2023-01-01) -
Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
by: Shengkui Tan, et al.
Published: (2022-08-01)